ReviewIndian journal of ophthalmology2016
Pathology of eyelid tumors.
Review in Indian journal of ophthalmology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 119 citations in OpenAlex.
- Clinical Application of Eyelid Composite Tissue Flap in the Repair of Full-thickness Eyelid Margin Defects.Plastic and reconstructive surgery. Global open · 2026Article
- A 5-year retrospective review of post-Mohs reconstruction outcomes for periocular cutaneous malignancies at an academic medical center.Frontiers in ophthalmology · 2026Article
- Histopathological spectrum of ocular masses in a tertiary eye center in Northern China: a 12-year retrospective analysis.Frontiers in medicine · 2026Article
- A comprehensive scientometric analysis of eyelid tumor research: co-word mapping and thematic clustering based on scopus data.International ophthalmology · 2025Article
- The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management.Cancers · 2025Review
- Article
- Population-Based Incidence and Clinical Characteristics of Ocular Adnexal Tumors in Olmsted County, Minnesota.Ophthalmic epidemiology · 2025Article
- Impact of clinicopathological features of meibomian gland adenocarcinoma on the outcomes of surgical resection combined with eyelid reconstruction.American journal of cancer research · 2025Article
- Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited.Wiener klinische Wochenschrift · 2025Article
- Benign eyelid lesions and its histopathological picture: A case-series.Journal of family medicine and primary care · 2024Article
- Squamous cell carcinoma of the eyelid: A rare tumor with unusual metastasis: A case report.Radiology case reports · 2024Article
- Upper and Lower Eyelid Malignancies: Differences in Clinical Presentation, Metastasis, and Treatment.Archives of dermatological research · 2024Review
- Complications and Recurrences after Excision and Reconstruction of Eyelid Tumours.Current oncology (Toronto, Ont.) · 2024Article
- Comparison of the clinical characteristics of benign and malignant eyelid lesions: an analysis of 1423 eyelid lesions, compared between ophthalmology department and plastics department.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024Article
- Squamous cell carcinoma of the eyelid.Japanese journal of clinical oncology · 2024Article
- Isolated cavernous venous malformation of the eyelid.Digital journal of ophthalmology : DJO · 2024Article
- HPV-Associated Squamous Cell Carcinoma of the Eyelid: Diagnostic Utility of p16 Immunohistochemistry and mRNA In Situ Hybridization.Head and neck pathology · 2023Article
- Article
- Clinicopathological analysis of eyelid lesions in Sri Lanka.International ophthalmology · 2023Article
- Eyes, menstruation and endometriosis.Facts, views & vision in ObGyn · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The eyelids are composed of four layers: skin and subcutaneous tissue including its adnexa, striated muscle, tarsus with the meibomian glands, and the palpebral conjunctiva. Benign and malignant tumors can arise from each of the eyelid layers. Most eyelid tumors are of cutaneous origin, mostly epidermal, which can be divided into epithelial and melanocytic tumors. Benign epithelial lesions, cystic lesions, and benign melanocytic lesions are very common. The most common malignant eyelid tumors are basal cell carcinoma in Caucasians and sebaceous gland carcinoma in Asians. Adnexal and stromal tumors are less frequent. The present review describes the more important eyelid tumors according to the following groups: Benign and malignant epithelial tumors, benign and malignant melanocytic tumors, benign and malignant adnexal tumors, stromal eyelid tumors, lymphoproliferative and metastatic tumors, other rare eyelid tumors, and inflammatory and infections lesions that simulate neoplasms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.